Econ Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.66M Buy
7,335
+1,035
+16% +$220K 0.69% 57
2026
Q2
$1.36M Buy
6,300
+1,903
+43% +$364K 0.64% 53
2026
Q1
$806K Buy
4,397
+451
+11% +$83.1K 0.37% 64
2025
Q4
$694K Buy
+3,946
New +$645K 0.35% 63

Other funds holding BIIB

Econ Financial Services's BIIB Position: Q3 2026 in Review

Econ Financial Services increased its Biogen (BIIB) stake by 16% in Q3 2026, buying an estimated $220K and bringing the position to 7,335 shares worth $1.66M. The position accounts for 0.69% of the portfolio, ranked #57.

Econ Financial Services first reported a position in BIIB in Q4 2025 and has held it in 4 quarters since. 579 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Econ Financial Services held 7,335 shares of Biogen worth $1.66M as of Q3 2026.
  • Econ Financial Services bought 1,035 Biogen shares in Q3 2026, an estimated $220K.
  • Biogen made up 0.69% of Econ Financial Services's portfolio in Q3 2026, its #57 holding.
  • Econ Financial Services first reported a position in Biogen in Q4 2025 and has held it in 4 quarters since.
  • 579 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Econ Financial Services's 13F filing for Q3 2026, filed 19 Oct 2026.